178 related articles for article (PubMed ID: 36434890)
1. Can healthcare choice be predicted using stated preference data? The role of model complexity in a discrete choice experiment about colorectal cancer screening.
Huls SPI; de Bekker-Grob EW
Soc Sci Med; 2022 Dec; 315():115530. PubMed ID: 36434890
[TBL] [Abstract][Full Text] [Related]
2. Can healthcare choice be predicted using stated preference data?
de Bekker-Grob EW; Donkers B; Bliemer MCJ; Veldwijk J; Swait JD
Soc Sci Med; 2020 Feb; 246():112736. PubMed ID: 31887626
[TBL] [Abstract][Full Text] [Related]
3. Are Healthcare Choices Predictable? The Impact of Discrete Choice Experiment Designs and Models.
de Bekker-Grob EW; Swait JD; Kassahun HT; Bliemer MCJ; Jonker MF; Veldwijk J; Cong K; Rose JM; Donkers B
Value Health; 2019 Sep; 22(9):1050-1062. PubMed ID: 31511182
[TBL] [Abstract][Full Text] [Related]
4. Decision-makers' preferences for approving new medicines in Wales: a discrete-choice experiment with assessment of external validity.
Linley WG; Hughes DA
Pharmacoeconomics; 2013 Apr; 31(4):345-55. PubMed ID: 23516033
[TBL] [Abstract][Full Text] [Related]
5. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
[TBL] [Abstract][Full Text] [Related]
6. Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment.
Mohammadi T; Bansback N; Marra F; Khakban A; Campbell JR; FitzGerald JM; Lynd LD; Marra CA
Value Health; 2017; 20(7):969-975. PubMed ID: 28712627
[TBL] [Abstract][Full Text] [Related]
7. What Factors Influence Non-Participation Most in Colorectal Cancer Screening? A Discrete Choice Experiment.
de Bekker-Grob EW; Donkers B; Veldwijk J; Jonker MF; Buis S; Huisman J; Bindels P
Patient; 2021 Mar; 14(2):269-281. PubMed ID: 33150461
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment.
Brinkmann M; Diedrich L; Hemmerling M; Krauth C; Robra BP; Stahmeyer JT; Dreier M
Value Health; 2023 Jan; 26(1):104-114. PubMed ID: 36031478
[TBL] [Abstract][Full Text] [Related]
9. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening.
de Bekker-Grob EW; Hol L; Donkers B; van Dam L; Habbema JD; van Leerdam ME; Kuipers EJ; Essink-Bot ML; Steyerberg EW
Value Health; 2010; 13(2):315-23. PubMed ID: 19912597
[TBL] [Abstract][Full Text] [Related]
10. Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments.
Wortley S; Wong G; Kieu A; Howard K
Patient; 2014; 7(3):271-82. PubMed ID: 24652475
[TBL] [Abstract][Full Text] [Related]
11. Attributes in stated preference elicitation studies on colorectal cancer screening and their relative importance for decision-making among screenees: a systematic review.
Brinkmann M; Fricke LM; Diedrich L; Robra BP; Krauth C; Dreier M
Health Econ Rev; 2022 Sep; 12(1):49. PubMed ID: 36136248
[TBL] [Abstract][Full Text] [Related]
12. Empirical Testing of the External Validity of a Discrete Choice Experiment to Determine Preferred Treatment Option: The Case of Sleep Apnea.
Krucien N; Gafni A; Pelletier-Fleury N
Health Econ; 2015 Aug; 24(8):951-65. PubMed ID: 24986760
[TBL] [Abstract][Full Text] [Related]
13. How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity.
Quaife M; Terris-Prestholt F; Di Tanna GL; Vickerman P
Eur J Health Econ; 2018 Nov; 19(8):1053-1066. PubMed ID: 29380229
[TBL] [Abstract][Full Text] [Related]
14. Attributes Used for Cancer Screening Discrete Choice Experiments: A Systematic Review.
Hall R; Medina-Lara A; Hamilton W; Spencer AE
Patient; 2022 May; 15(3):269-285. PubMed ID: 34671946
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment.
Heidenreich S; Finney Rutten LJ; Miller-Wilson LA; Jimenez-Moreno C; Chua GN; Fisher DA
Cancer Med; 2022 Aug; 11(16):3156-3167. PubMed ID: 35315224
[TBL] [Abstract][Full Text] [Related]
16. How psychological distance of a study sample in discrete choice experiments affects preference measurement: a colorectal cancer screening case study.
Veldwijk J; Groothuis-Oudshoorn CGM; Kihlbom U; Langenskiöld S; Dekker E; Kallenberg FGJ; de Wit GA; Lambooij MS
Patient Prefer Adherence; 2019; 13():273-282. PubMed ID: 30863017
[TBL] [Abstract][Full Text] [Related]
17. Getting it right with discrete choice experiments: Are we hot or cold?
Ozdemir S; Gonzalez JM; Bansal P; Huynh VA; Sng BL; Finkelstein E
Soc Sci Med; 2024 May; 348():116850. PubMed ID: 38608481
[TBL] [Abstract][Full Text] [Related]
18. Accounting for Scale Heterogeneity in Healthcare-Related Discrete Choice Experiments when Comparing Stated Preferences: A Systematic Review.
Wright SJ; Vass CM; Sim G; Burton M; Fiebig DG; Payne K
Patient; 2018 Oct; 11(5):475-488. PubMed ID: 29492903
[TBL] [Abstract][Full Text] [Related]
19. Estimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in Thailand.
Phisalprapa P; Ngorsuraches S; Wanishayakorn T; Kositamongkol C; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2021; 24(1):226-233. PubMed ID: 33467947
[TBL] [Abstract][Full Text] [Related]
20. Preferences of Iranian average risk population for colorectal cancer screening tests.
Ramezani Doroh V; Delavari A; Yaseri M; Emamgholipour Sefiddashti S; Akbarisari A
Int J Health Care Qual Assur; 2019 May; 32(4):677-687. PubMed ID: 31111783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
